Prognostic factors in children with Ewing's sarcoma

Area of Science:

• Pediatric Oncology
• Skeletal System Neoplasms
• Clinical Trial Analysis

Background:

• Ewing sarcoma is a rare bone cancer primarily affecting children and young adults.
• Prognostic factors in Ewing sarcoma require detailed investigation to improve patient outcomes.
• Understanding patient characteristics is crucial for tailoring treatment and predicting survival.

Purpose of the Study:

• To examine patient characteristics influencing prognosis in a cohort of Ewing sarcoma patients.
• To identify key prognostic variables for disease-free and overall survival.
• To analyze the impact of primary tumor site, sex, and treatment on survival.

Main Methods:

• Multivariate regression analysis of 272 patients from a clinical trial (1972-1978).
• Evaluation of prognostic significance of primary disease site, sex, liver function, surgical intervention, blood counts, and time to diagnosis.
• Comparison of survival times based on treatment regimens.

Main Results:

• Primary tumor site was the strongest prognostic factor; pelvic sites had the poorest prognosis, while distal sites had the most favorable.
• Females exhibited better prognoses than males. Abnormal liver function (elevated SGOT) indicated a poor prognosis.
• High lymphocyte counts and shorter time from symptoms to diagnosis were favorable. Treatment regimen 2 was associated with significantly poorer prognoses.

Conclusions:

• Primary tumor site is a critical determinant of Ewing sarcoma prognosis.
• Patient sex, specific laboratory values, and timely diagnosis significantly impact survival.
• Treatment protocols and surgical approach may influence outcomes, necessitating further research.